title: Bleomycin-induced flagellate dermatitis.
abstract: Flagellate dermatitis shows very characteristic lesions: linear erythema or hyperpigmentation in various areas of the skin. It is a side effect of bleomycin, an immunosupressive drug used for several types of cancers. All physicians must be aware of this disease so they can make a rapid diagnosis and interrupt the causative agent. Our patient presented during chemotherapy for a Hodgkin's lymphoma pruritic, erythematous lesions on the lower limbs and the back diagnosed as flagellate dermatitis due to bleomycin.
authors.affiliation: Sector of Dermatology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Rachel
authors.initials: R
authors.lastname: Grynszpan
authors.forename: João Paulo
authors.initials: JP
authors.lastname: Niemeyer-Corbellini
authors.forename: Marien Siqueira Soto
authors.initials: MS
authors.lastname: Lopes
authors.forename: Marcia
authors.initials: M
authors.lastname: Ramos-e-Silva
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D017495:Hyperpigmentation / Q000209:etiology / Q000473:pathology*
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin